By creating centres of excellence around the world, J&J is expected to gain the flexibility and resources to invest from early to later stages and work with different types of entrepreneurs - whether from academia, venture capital-backed companies or incubating ideas internally.

US-based healthcare group Johnson & Johnson (J&J) is preparing a shake up of its innovation teams to be based in four centres, in California and Boston in the US, in the UK and in Shanghai, China. Paul Stoffels, currently chairman of J&J’s pharmaceutical group research and development and chairman of the Johnson & Johnson Development…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.